Immunologic monitoring in kidney transplant recipients

Kidney Research and Clinical Practice

Volumn 32, Issue 2, 2013, Pages 52-61

  Townamchai, Natavudh ^a,b   Safa, Kassem ^b   Chandraker, Anil ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Immunology; Kidney transplant; Monitoring; Recipient

Indexed keywords

ADENOSINE TRIPHOSPHATE; BELATACEPT; CALCINEURIN INHIBITOR; CD30 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; HLA ANTIBODY; IMMUNOSUPPRESSIVE AGENT; SOLUBLE CD30 ANTIGEN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; CELL MEDIATED CYTOTOXICITY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOLOGICAL MONITORING; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MIXED LYMPHOCYTE REACTION; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW;

EID: 84879222522     PISSN: 22119132     EISSN: 22119140     Source Type: Journal    
DOI: 10.1016/j.krcp.2013.04.002     Document Type: Review

References (104)

1. A. Chandraker Diagnostic techniques in the work-up of renal allograft dysfunction - an update Curr Opin Nephrol Hypertens 8 1999 723 728
2. B.L. Kasiske, R.S. Gaston, S. Gourishankar, P.F. Halloran, A.J. Matas, J. Jeffery, and D. Rush Long-term deterioration of kidney allograft function Am J Transplant 5 2005 1405 1414
3. M.H. Sayegh, and C.B. Carpenter Transplantation 50 years later - progress, challenges, and promises N Engl J Med 351 2004 2761 2766
4. P.I. Terasaki, M. Kreisler, and R.M. Mickey Presensitization and kidney transplant failures Postgrad Med J 47 1971 89 100
5. R. Patel, and P.I. Terasaki Significance of the positive crossmatch test in kidney transplantation N Engl J Med 280 1969 735 739
6. R. Pei, J.H. Lee, N.J. Shih, M. Chen, and P.I. Terasaki Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities Transplantation 75 2003 43 49
7. X. Li, H. Ishida, Y. Yamaguchi, and K. Tanabe Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation Transpl Int 21 2008 1145 1152
8. B. Sis, M. Mengel, M. Haas, R.B. Colvin, P.F. Halloran, L.C. Racusen, K. Solez, W.M. Baldwin 3rd, E.R. Bracamonte, V. Broecker, F. Cosio, A.J. Demetris, C. Drachenberg, G. Einecke, J. Gloor, D. Glotz, E. Kraus, C. Legendre, H. Liapis, R.B. Mannon, B.J. Nankivell, V. Nickeleit, J.C. Papadimitriou, P. Randhawa, H. Regele, K. Renaudin, E.R. Rodriguez, D. Seron, S. Seshan, M. Suthanthiran, B.A. Wasowska, A. Zachary, and A. Zeevi Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups Am J Transplant 10 2010 464 471
9. J.M. Cecka Current methodologies for detecting sensitization to HLA antigens Curr Opin Organ Transplant 16 2011 398 403
10. W.R. Mulley, and J. Kanellis Understanding crossmatch testing in organ transplantation: a case-based guide for the general nephrologist Nephrology (Carlton) 16 2011 125 133
11. A.M. Patel, C. Pancoska, S. Mulgaonkar, and F.L. Weng Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches Am J Transplant 7 2007 2371 2377
12. R.A. Montgomery, B.E. Lonze, K.E. King, E.S. Kraus, L.M. Kucirka, J.E. Locke, D.S. Warren, C.E. Simpkins, N.N. Dagher, A.L. Singer, A.A. Zachary, and D.L. Segev Desensitization in HLA-incompatible kidney recipients and survival N Engl J Med 365 2011 318 326
13. K. Marfo, A. Lu, M. Ling, and E. Akalin Desensitization protocols and their outcome Clin J Am Soc Nephrol 6 2011 922 936
14. I.S. Ntokou, A.G. Iniotaki, E.N. Kontou, M.N. Darema, M.D. Apostolaki, A.G. Kostakis, and J.N. Boletis Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules Transpl Int 24 2011 1084 1093
15. P.I. Terasaki, M. Ozawa, and R. Castro Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival Am J Transplant 7 2007 408 415
16. H. Ishida, T. Hirai, N. Kohei, Y. Yamaguchi, and K. Tanabe Significance of qualitative and quantitative evaluations of anti-HLA antibodies in kidney transplantation Transpl Int 24 2011 150 157
17. W. Weimar, J. Rischen-Vos, P. de Kuiper, P.J. Gregoor, I.J. JN, N.M. van Besouw, C.C. Baan, and B.J. van der Mast Tapering immunosuppression in recipients of living donor kidney transplants Nephrol Dial Transplant 19 Suppl 4 2004 iv61 iv63
18. N.M. van Besouw, B.J. van der Mast, P. de Kuiper, P.J. Smak Gregoor, L.M. Vaessen, J.N. IJzermans, T. van Gelder, and W. Weimar Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced Transplantation 70 2000 136 143
19. N.L. Reinsmoen Cellular methods used to evaluate the immune response in transplantation Tissue antigens 59 2002 241 250
20. B.S. Gebauer, D.E. Hricik, A. Atallah, K. Bryan, J. Riley, M. Tary-Lehmann, N.S. Greenspan, C. Dejelo, B.O. Boehm, B.J. Hering, and P.S. Heeger Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool Am J Transplant 2 2002 857 866
21. N. Babel, P. Reinke, and H.D. Volk Lymphocyte markers and prediction of long-term renal allograft acceptance Curr Opin Nephrol Hypertens 18 2009 489 494
22. B.J. Nather, P. Nickel, G. Bold, F. Presber, C. Schonemann, J. Pratschke, H.D. Volk, and P. Reinke Modified ELISPOT technique - highly significant inverse correlation of post-Tx donor-reactive IFN gamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients Transpl Immunol 16 2006 232 237
23. P. Nickel, F. Presber, G. Bold, D. Biti, C. Schonemann, S.G. Tullius, H.D. Volk, and P. Reinke Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients Transplantation 78 2004 1640 1646
24. N. Najafian, A.D. Salama, E.V. Fedoseyeva, G. Benichou, and M.H. Sayegh Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients J Am Soc Nephrol 13 2002 252 259
25. S.H. Kim, E.J. Oh, M.J. Kim, Y.J. Park, K. Han, H.J. Yang, J.Y. Kim, B.S. Choi, C.W. Yang, Y.S. Kim, and B.K. Bang Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients Transplant Proc 39 2007 3057 3060
26. N.L. Reinsmoen, K.M. Cornett, R. Kloehn, A.D. Burnette, L. McHugh, B.K. Flewellen, A. Matas, and K. Savik Pretransplant donor-specific and non-specific immune parameters associated with early acute rejection Transplantation 85 2008 462 470
27. O. Bestard, P. Nickel, J.M. Cruzado, C. Schoenemann, O. Boenisch, A. Sefrin, J.M. Grinyo, H.D. Volk, and P. Reinke Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients J Am Soc Nephrol 19 2008 1419 1429
28. L. Cherkassky, M. Lanning, P.N. Lalli, J. Czerr, H. Siegel, L. Danziger-Isakov, T. Srinivas, A. Valujskikh, D.A. Shoskes, W. Baldwin, R.L. Fairchild, and E.D. Poggio Evaluation of alloreactivity in kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker Am J Transplant 11 2011 1388 1396
29. E.D. Poggio, J.J. Augustine, M. Clemente, J.M. Danzig, N. Volokh, M.S. Zand, D.E. Hricik, and P.S. Heeger Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection Transplantation 83 2007 847 852
30. S. Heidt, D.L. Roelen, Y.J. de Vaal, M.G. Kester, C. Eijsink, S. Thomas, N.M. van Besouw, H.D. Volk, W. Weimar, F.H. Claas, and A. Mulder A novel ELISPOT assay to quantify HLA-specific B cells in HLA-immunized individuals Am J Transplant 12 2012 1469 1478
31. R.J. Kowalski, D.R. Post, R.B. Mannon, A. Sebastian, H.I. Wright, G. Sigle, J. Burdick, K.A. Elmagd, A. Zeevi, M. López-Cepero, J.A. Daller, H.A. Gritsch, E.F. Reed, J. Jonsson, D. Hawkins, and J.A. Britz Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay Transplantation 82 2006 663 668
32. I. Perez-Flores, A. Sanchez-Fructuoso, J.L. Santiago, M. Fernandez-Arquero, N. Calvo, E.G. de la Concha, and A. Barrientos Intracellular ATP levels in CD4+ lymphocytes are a risk marker of rejection and infection in renal graft recipients Transplant Proc 41 2009 2106 2108
33. J. Huskey, J. Gralla, and A.C. Wiseman Single time point immune function assay (ImmuKnow) testing does not aid in the prediction of future opportunistic infections or acute rejection Clin J Am Soc Nephrol 6 2011 423 429
34. G. Serban, V. Whittaker, J. Fan, Z. Liu, K. Manga, M. Khan, K. Kontogianni, A. Padmanabhan, D. Cohen, N. Suciu-Foca, L. Ratner, and A.I. Colovai Significance of immune cell function monitoring in renal transplantation after Thymoglobulin induction therapy Hum Immunol 70 2009 882 890
35. X. Ling, J. Xiong, W. Liang, P.M. Schroder, L. Wu, W. Ju, Y. Kong, Y. Shang, Z. Guo, and X. He Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis Transplantation 93 2012 737 743
36. H. Zhou, Z. Wu, L. Ma, W. Wu, S. Yang, Q. Wang, X. Yuan, L. Wu, X. Lin, and J. Tan Assessing immunologic function through CD4 T-lymphocyte ahenosine triphosphate levels by ImmuKnow assay in Chinese patients following renal transplantation Transplant Proc 43 2011 2574 2578
37. M.K. Kennedy, C.R. Willis, and R.J. Armitage Deciphering CD30 ligand biology and its role in humoral immunity Immunology 118 2006 143 152
38. W. Altermann, G. Schlaf, A. Rothhoff, and B. Seliger High variation of individual soluble serum CD30 levels of pre-transplantation patients: sCD30 a feasible marker for prediction of kidney allograft rejection? Nephrol Dial Transplant 22 2007 2795 2799
39. P. Cinti, R. Pretagostini, A. Arpino, M.L. Tamburro, S. Mengasini, R. Lattanzi, P. De Simone, P. Berloco, and E.R. Molajoni Evaluation of pretransplant immunologic status in kidney-transplant recipients by panel reactive antibody and soluble CD30 determinations Transplantation 79 2005 1154 1156
40. C. Süsal, S. Pelzl, and G. Opelz Strong human leukocyte antigen matching effect in nonsensitized kidney recipients with high pretransplant soluble CD30 Transplantation 76 2003 1231 1232
41. S. Sengul, K. Keven, U. Gormez, S. Kutlay, S. Erturk, and B. Erbay Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation Transplantation 81 2006 1216 1219
42. G. Barbano, F. Cappa, I. Prigione, V. Pistoia, A. Cohen, S. Chiesa, R. Gusmano, and F. Perfumo Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone Nephrol Dial Transplant 16 2001 1807 1813
43. S. Pelzl, G. Opelz, V. Daniel, M. Wiesel, and C. Süsal Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection Transplantation 75 2003 421 423
44. R. Weimer, C. Süsal, S. Yildiz, A. Staak, S. Pelzl, F. Renner, H. Dietrich, V. Daniel, S. Kamali-Ernst, W. Ernst, W. Padberg, and G. Opelz Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens Am J Transplant 6 2006 1865 1874
45. R. Hamer, L. Roche, D. Smillie, A. Harmer, D. Mitchell, G. Molostvov, F.T. Lam, H. Kashi, L.C. Tan, C. Imray, S. Fletcher, D. Briggs, D. Lowe, D. Zehnder, and R. Higgins Soluble CD30 and Cd27 levels in patients undergoing HLA antibody-incompatible renal transplantation Transpl Immunol 23 2010 161 165
46. L.L. Langan, L. D'Orsogna, L.P. Park, T.L. Hughes, A. Irish, G. Luxton, C.S. Witt, and F.T. Christiansen HLA antibodies and soluble CD30 are associated with poor renal graft outcome: updated results of a single-center cross-sectional study Clin Transpl 2006 219 225
47. J.L. Yang, H.J. Hao, B. Zhang, Y.X. Liu, S. Chen, and Y.Q. Na Level of soluble CD30 after kidney transplantation correlates with acute rejection episodes Transplant Proc 40 2008 3381 3383
48. E.M. Domingues, T. Matuck, M.L. Graciano, E. Souza, S. Rioja, and M.C. Falci Monteiro de Carvalho DB, Porto LC: Panel reactive HLA antibodies, soluble CD30 levels, and acute rejection six months following renal transplant Clin Transplant 24 2010 821 829
49. D. Wang, G.J. Wu, W.Z. Wu, S.L. Yang, J.H. Chen, H. Wang, W.H. Lin, Q.H. Wang, Z.X. Zeng, and J.M. Tan Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection Transpl Immunol 17 2007 278 282
50. A. Slavcev, E. Honsova, A. Lodererova, Y. Pavlova, H. Sajdlova, S. Vitko, J. Skibova, I. Striz, and O. Viklicky Soluble CD30 in patients with antibody-mediated rejection of the kidney allograft TransplImmunol 18 2007 22 27
51. R.E. Platt, K.S. Wu, K. Poole, C.G. Newstead, and B. Clark Soluble CD30 as a prognostic factor for outcome following renal transplantation J Clin Pathol 62 2009 662 663
52. M. Lopez-Hoyos, D. San Segundo, M.J. Benito, G. Fernandez-Fresnedo, J.C. Ruiz, E. Rodrigo, C. Gomez-Alamillo, A. Benito, and M. Arias Association between serum soluble CD30 and serum creatinine before and after renal transplantation Transplant Proc 40 2008 2903 2905
53. K. Nakao, Y. Nagake, A. Okamoto, H. Ichikawa, M. Yamamura, and H. Makino Serum levels of soluble CD26 and CD30 in patients on hemodialysis Nephron 91 2002 215 221
54. S. Chrul, and E. Polakowska Age-dependent changes of serum soluble CD30 concentration in children Pediatr Transplant 15 2011 515 518
55. M.T. Dieterlen, K. Eberhardt, A. Tarnok, H.B. Bittner, and M.J. Barten Flow cytometry-based pharmacodynamic monitoring after organ transplantation Methods Cell Biol 103 2011 267 284
56. J.P. Pearl, J. Parris, D.A. Hale, S.C. Hoffmann, W.B. Bernstein, K.L. McCoy, S.J. Swanson, R.B. Mannon, M. Roederer, and A.D. Kirk Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion Am J Transplant 5 2005 465 474
57. N. Seddiki, B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S.I. Alexander, R. Nanan, and A. Kelleher Fazekas de St Groth B: Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells J Exp Med 203 2006 1693 1700
58. S. Heidt, D. San Segundo, S. Shankar, S. Mittal, A.S. Muthusamy, P.J. Friend, S.V. Fuggle, and K.J. Wood Peripheral blood sampling for the detection of allograft rejection: biomarker identification and validation Transplantation 92 2011 1 9
59. S. Sakaguchi, M. Miyara, C.M. Costantino, and D.A. Hafler FOXP3+ regulatory T cells in the human immune system Nat Rev Immunol 10 2010 490 500
60. K.J. Wood, and S. Sakaguchi Regulatory T cells in transplantation tolerance Nat Rev Immunol 3 2003 199 210
61. L. Vallotton, K. Hadaya, J.P. Venetz, L.H. Buehler, D. Ciuffreda, G. Nseir, L. Codarri, J. Villard, G. Pantaleo, and M. Pascual Monitoring of CD4+CD25highIL-7Ralphahigh activated T cells in kidney transplant recipients Clin J Am Soc Nephrol 6 2011 2025 2033
62. C. Braudeau, M. Racape, M. Giral, S. Louis, A. Moreau, L. Berthelot, M. Heslan, J. Ashton-Chess, J.P. Soulillou, and S. Brouard Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome Transpl Int 20 2007 845 855
63. D.Q. Tran, J. Andersson, D. Hardwick, L. Bebris, G.G. Illei, and E.M. Shevach Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures Blood 113 2009 5125 5133
64. M.L. Chen, B.S. Yan, Y. Bando, V.K. Kuchroo, and H.L. Weiner Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis J Immunol 180 2008 7327 7337
65. D. San Segundo, and E. Fabrega Reduced numbers of blood natural regulatory T cells in stable liver transplant recipients with high levels of calcineurin inhibitors Transplant Proc 39 2007 2290 2292
66. D.S. Segundo, J.C. Ruiz, M. Izquierdo, G. Fernandez-Fresnedo, C. Gomez-Alamillo, R. Merino, M.J. Benito, E. Cacho, E. Rodrigo, R. Palomar, M. Lopez-Hoyos, and M. Arias Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients Transplantation 82 2006 550 557
67. A. Demirkiran, A. Kok, J. Kwekkeboom, H.J. Metselaar, H.W. Tilanus, and L.J. van der Laan Decrease of CD4+CD25+ T cells in peripheral blood after liver transplantation: association with immunosuppression Transplant Proc 37 2005 1194 1196
68. T.K. Hendrikx, J.H. Velthuis, M. Klepper, E. van Gurp, A. Geel, W. Schoordijk, C.C. Baan, and W. Weimar Monotherapy rapamycin allows an increase of CD4 CD25 FoxP3 T cells in renal recipients Transpl Int 22 2009 884 891
69. F. Vincenti, G. Blancho, A. Durrbach, P. Friend, J. Grinyo, P.F. Halloran, J. Klempnauer, P. Lang, C.P. Larsen, F. Muhlbacher, B. Nashan, J.P. Soulillou, Y. Vanrenterghem, T. Wekerle, M. Agarwal, S. Gujrathi, J. Shen, R. Shi, R. Townsend, and B. Charpentier Five-year safety and efficacy of belatacept in renal transplantation J Am Soc Nephrol 21 2010 1587 1596
70. B. Salomon, D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, and J.A. Bluestone B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes Immunity 12 2000 431 440
71. J.A. Bluestone, W. Liu, J.M. Yabu, Z.G. Laszik, A. Putnam, M. Belingheri, D.M. Gross, R.M. Townsend, and F. Vincenti The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation Am J Transplant 8 2008 2086 2096
72. I.F. Ashoor, and N. Najafian Rejection and regulation: a tight balance Curr Opin Organ Transplant 17 2012 1 7
73. A. Pallier, S. Hillion, R. Danger, M. Giral, M. Racape, N. Degauque, E. Dugast, J. Ashton-Chess, S. Pettre, J.J. Lozano, R. Bataille, A. Devys, A. Cesbron-Gautier, C. Braudeau, C. Larrose, J.P. Soulillou, and S. Brouard Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype Kidney Int 78 2010 503 513
74. P. Sagoo, E. Perucha, B. Sawitzki, S. Tomiuk, D.A. Stephens, P. Miqueu, S. Chapman, L. Craciun, R. Sergeant, S. Brouard, F. Rovis, E. Jimenez, A. Ballow, M. Giral, I. Rebollo-Mesa, A. Le Moine, C. Braudeau, R. Hilton, B. Gerstmayer, K. Bourcier, A. Sharif, M. Krajewska, G.M. Lord, I. Roberts, M. Goldman, K.J. Wood, K. Newell, V. Seyfert-Margolis, A.N. Warrens, U. Janssen, H.D. Volk, J.P. Soulillou, M.P. Hernandez-Fuentes, and R.I. Lechler Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans J Clin Invest 120 2010 1848 1861
75. K.A. Newell, A. Asare, A.D. Kirk, T.D. Gisler, K. Bourcier, M. Suthanthiran, W.J. Burlingham, W.H. Marks, I. Sanz, R.I. Lechler, M.P. Hernandez-Fuentes, L.A. Turka, and V.L. Seyfert-Margolis Identification of a B cell signature associated with renal transplant tolerance in humans J Clin Invest 120 2010 1836 1847
76. D. Anglicheau, and M. Suthanthiran Noninvasive prediction of organ graft rejection and outcome using gene expression patterns Transplantation 86 2008 192 199
77. T. Simon, G. Opelz, M. Wiesel, R.C. Ott, and C. Süsal Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients Am J Transplant 3 2003 1121 1127
78. L.M. Vasconcellos, A.D. Schachter, X.X. Zheng, L.H. Vasconcellos, M. Shapiro, W.E. Harmon, and T.B. Strom Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts Transplantation 66 1998 562 566
79. V. Zarkhin, and M.M. Sarwal Microarrays: monitoring for transplant tolerance and mechanistic insights Clin Lab Med 28 2008 385 410 vi
80. J.L. Veale, L.W. Liang, Q. Zhang, D.W. Gjertson, Z. Du, E.W. Bloomquist, J. Jia, L. Qian, A.H. Wilkinson, G.M. Danovitch, P.T. Pham, J.T. Rosenthal, C.R. Lassman, J. Braun, E.F. Reed, and H.A. Gritsch Noninvasive diagnosis of cellular and antibody-mediated rejection by perforin and granzyme B in renal allografts Hum Immunol 67 2006 777 786
81. B. Li, C. Hartono, R. Ding, V.K. Sharma, R. Ramaswamy, B. Qian, D. Serur, J. Mouradian, J.E. Schwartz, and M. Suthanthiran Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine N Engl J Med 344 2001 947 954
82. M.V. Netto, B.A. Fonseca, and M. Dantas Saber LT, Castro MC, Ferraz AS: Granzyme B, FAS-ligand and perforin expression during acute cellular rejection episodes after kidney transplantation: comparison between blood and renal aspirates Transplant Proc 34 2002 476 478
83. G.T. Shin, S.J. Kim, T.S. Lee, C.K. Oh, and H. Kim Gene expression of perforin by peripheral blood lymphocytes as a marker of acute rejection Nephron Clin Pract 100 2005 c63 c70
84. R. Graziotto, D. Del Prete, P. Rigotti, F. Anglani, N. Baldan, L. Furian, M. Valente, A. Antonello, F. Marchini, A. D'Angelo, and G. Gambaro Perforin, Granzyme B, and fas ligand for molecular diagnosis of acute renal-allograft rejection: analyses on serial biopsies suggest methodological issues Transplantation 81 2006 1125 1132
85. H. Iwase, T. Kobayashi, Y. Kodera, Y. Miwa, T. Kuzuya, K. Iwasaki, M. Haneda, A. Katayama, A. Takeda, K. Morozumi, Y. Watarai, K. Uchida, and A. Nakao Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation Transplantation 91 2011 191 198
86. C.M. Alvarez, G. Opelz, L.F. Garcia, and C. Süsal Expression of regulatory T-cell-related molecule genes and clinical outcome in kidney transplant recipients Transplantation 87 2009 857 863
87. P.M. Moraes-Vieira, M.C. Takenaka, H.M. Silva, S.M. Monteiro, F. Agena, F. Lemos, D. Saitovitch, J. Kalil, and V. Coelho GATA3 and a dominant regulatory gene expression profile discriminate operational tolerance in human transplantation Clin Immunol 142 2012 117 126
88. E.C. Aquino-Dias, G. Joelsons, D.M. da Silva, R.H. Berdichevski, A.R. Ribeiro, F.J. Veronese, L.F. Goncalves, and R.C. Manfro Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function Kidney Int 73 2008 877 884
89. T. Muthukumar, D. Dadhania, R. Ding, C. Snopkowski, R. Naqvi, J.B. Lee, C. Hartono, B. Li, V.K. Sharma, S.V. Seshan, S. Kapur, W.W. Hancock, J.E. Schwartz, M. Suthanthiran, and R.N.A. Messenger for FOXP3 in the urine of renal-allograft recipients N Engl J Med 353 2005 2342 2351
90. B. Sawitzki, S. Schlickeiser, P. Reinke, and H.D. Volk Monitoring tolerance and rejection in organ transplant recipients Biomarkers 16 Suppl 1 2011 S42 S50
91. B. Sawitzki, A. Bushell, U. Steger, N. Jones, K. Risch, A. Siepert, M. Lehmann, I. Schmitt-Knosalla, K. Vogt, I. Gebuhr, K. Wood, and H.D. Volk Identification of gene markers for the prediction of allograft rejection or permanent acceptance Am J Transplant 7 2007 1091 1102
92. S. Schaub, D. Rush, J. Wilkins, I.W. Gibson, T. Weiler, K. Sangster, L. Nicolle, M. Karpinski, J. Jeffery, and P. Nickerson Proteomic-based detection of urine proteins associated with acute renal allograft rejection J Am Soc Nephrol 15 2004 219 227
93. S. Schaub, J.A. Wilkins, M. Antonovici, O. Krokhin, T. Weiler, D. Rush, and P. Nickerson Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts Am J Transplant 5 2005 729 738
94. S. Schaub, M. Mayr, G. Honger, J. Bestland, J. Steiger, A. Regeniter, M.J. Mihatsch, J.A. Wilkins, D. Rush, and P. Nickerson Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology Transplantation 84 2007 104 112
95. S. Schaub, J.A. Wilkins, and P. Nickerson Proteomics and renal transplantation: searching for novel biomarkers and therapeutic targets Contrib Nephrol 160 2008 65 75
96. S. Schaub, P. Nickerson, D. Rush, M. Mayr, C. Hess, M. Golian, W. Stefura, and K. Hayglass Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis Am J Transplant 9 2009 1347 1353
97. E. O'Riordan, T.N. Orlova, J.J. Mei, K. Butt, P.M. Chander, S. Rahman, M. Mya, R. Hu, J. Momin, E.W. Eng, D.J. Hampel, B. Hartman, M. Kretzler, V. Delaney, and M.S. Goligorsky Bioinformatic analysis of the urine proteome of acute allograft rejection J Am Soc Nephrol 15 2004 3240 3248
98. E. O'Riordan, T.N. Orlova, V.N. Podust, P.N. Chander, S. Yanagi, M. Nakazato, R. Hu, K. Butt, V. Delaney, and M.S. Goligorsky Characterization of urinary peptide biomarkers of acute rejection in renal allografts Am J Transplant 7 2007 930 940
99. T.K. Sigdel, A. Kaushal, M. Gritsenko, A.D. Norbeck, W.J. Qian, W. Xiao, D.G. Camp 2nd, R.D. Smith, and M.M. Sarwal Shotgun proteomics identifies proteins specific for acute renal transplant rejection Proteomics Clin Appl 4 2010 32 47
100. Clarke W, Silverman BC, Zhang Z, Chan DW, Klein AS, Molmenti EP.: Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 237:660-664; discussion 664-665, 2003
101. W. Clarke Proteomic research in renal transplantation Ther Drug Monit 28 2006 19 22
102. S. Wittke, M. Haubitz, M. Walden, F. Rohde, A. Schwarz, M. Mengel, H. Mischak, H. Haller, and W. Gwinner Detection of acute tubulointerstitial rejection by proteomic analysis of urinary samples in renal transplant recipients Am J Transplant 5 2005 2479 2488
103. M. Naesens, and M.M. Sarwal Harnessing the diversity of the human T-cell repertoire: a monitoring tool for transplantation tolerance? Eur J Immunol 40 2010 2986 2989
104. P. Miqueu, N. Degauque, M. Guillet, M. Giral, C. Ruiz, A. Pallier, C. Braudeau, G. Roussey-Kesler, J. Ashton-Chess, J.C. Dore, E. Thervet, C. Legendre, M.P. Hernandez-Fuentes, A.N. Warrens, M. Goldman, H.D. Volk, U. Janssen, K.J. Wood, R.I. Lechler, D. Bertrand, V. Sebille, J.P. Soulillou, and S. Brouard Analysis of the peripheral T-cell repertoire in kidney transplant patients Eur J Immunol 40 2010 3280 3290